Beacon Capital Management LLC (Tennessee)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$406	–	1176
2025 Q1	$406	Buy	+5	New	+$447	﹤0.01%	1091
2023 Q2	–	Sell	-15	Closed	-$1.14K	–	1056
2023 Q1	$1.14K	Hold	15	–	–	﹤0.01%	829
2022 Q4	$1.25K	Hold	15	–	–	﹤0.01%	858
2022 Q3	$1K	Buy	+15	New	+$1.26K	﹤0.01%	859

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s XBI Position: Q2 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 5 shares — an estimated $406 sold.

Beacon Capital Management LLC (Tennessee) first reported a position in XBI in Q3 2022 and held it in 4 quarters. The position peaked at $1.25K in Q4 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 5 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $406.
Beacon Capital Management LLC (Tennessee) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 4 quarters.
Beacon Capital Management LLC (Tennessee)'s State Street SPDR S&P Biotech ETF position peaked at $1.25K in Q4 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2025, filed 17 Jul 2025.